Volume 16 - Issue 9 - September 2008
09/22/2008
According to information provided by the Melanoma Research Foundation (MRF), the health benefits of vitamin D — which can be gotten safely from diet and supplements — through sunlight exposure are greatly outweighed by the risks associated...
According to information provided by the Melanoma Research Foundation (MRF), the health benefits of vitamin D — which can be gotten safely from diet and supplements — through sunlight exposure are greatly outweighed by the risks associated...
According to information...
09/22/2008
The Dermatologist
News
News
09/22/2008
Renovo’s Phase II trial for Juvista in scar revision surgery has met its primary endpoint. The randomized, double-blind, placebo-controlled study investigated the safety and efficacy of Juvista given at the time of surgery following wound...
Renovo’s Phase II trial for Juvista in scar revision surgery has met its primary endpoint. The randomized, double-blind, placebo-controlled study investigated the safety and efficacy of Juvista given at the time of surgery following wound...
Renovo’s Phase II trial for...
09/22/2008
The Dermatologist
News
09/22/2008
LEO Pharma’s new drug for treatment of scalp psoriasis, Xamiol, has been approved in 16 European countries. The UK will be the first country to market Xamiol. In extensive clinical studies, Xamiol has proved to be a very efficient drug in the...
LEO Pharma’s new drug for treatment of scalp psoriasis, Xamiol, has been approved in 16 European countries. The UK will be the first country to market Xamiol. In extensive clinical studies, Xamiol has proved to be a very efficient drug in the...
LEO Pharma’s new drug for...
09/22/2008
The Dermatologist
News
09/22/2008
Galderma recently announced that Japan’s Ministry of Health, Labor and Welfare has approved adapalene (Differin Gel 0.1%), a novel topical treatment for acne vulgaris. The drug will be marketed in Japan by Galderma KK, the fully-owned...
Galderma recently announced that Japan’s Ministry of Health, Labor and Welfare has approved adapalene (Differin Gel 0.1%), a novel topical treatment for acne vulgaris. The drug will be marketed in Japan by Galderma KK, the fully-owned...
Galderma recently announced that...
09/22/2008
The Dermatologist
News
09/22/2008
The FDA approved Aurobindo Pharma’s generic version of the injectable antibiotic cefazolin made by Abraxis Pharmaceutical. Cefazolin, a cephalosporin antibiotic, is used to eliminate bacteria that cause different types of infections,...
The FDA approved Aurobindo Pharma’s generic version of the injectable antibiotic cefazolin made by Abraxis Pharmaceutical. Cefazolin, a cephalosporin antibiotic, is used to eliminate bacteria that cause different types of infections,...
The FDA approved Aurobindo...
09/22/2008
The Dermatologist
News
09/22/2008
Iridex Corporation recently announced its receipt of FDA 510(k) clearance for its Family of Iridex IQ Laser Systems. This clearance covers the Iridex IQ 532, IQ 577, IQ 630-670 and IQ 810 Laser Systems and their associated delivery devices to...
Iridex Corporation recently announced its receipt of FDA 510(k) clearance for its Family of Iridex IQ Laser Systems. This clearance covers the Iridex IQ 532, IQ 577, IQ 630-670 and IQ 810 Laser Systems and their associated delivery devices to...
Iridex Corporation recently...
09/22/2008
The Dermatologist
News
09/22/2008
The FDA recently announced that the manufacturers of tumor necrosis factor alpha blockers (TNF-alpha blockers) must strengthen the existing warnings about the risk of developing opportunistic fungal infections when taking these drugs. These...
The FDA recently announced that the manufacturers of tumor necrosis factor alpha blockers (TNF-alpha blockers) must strengthen the existing warnings about the risk of developing opportunistic fungal infections when taking these drugs. These...
The FDA recently announced that...
09/22/2008
The Dermatologist
Column
Chief Medical Editor Message
09/22/2008
In our 10th Annual Laser Surgery Issue, we hope you’ll glean tips to enhance light and laser procedures you’re already performing or find out about a new technology that could benefit your practice.
A Look at the Issue
This month’s...
In our 10th Annual Laser Surgery Issue, we hope you’ll glean tips to enhance light and laser procedures you’re already performing or find out about a new technology that could benefit your practice.
A Look at the Issue
This month’s...
In our 10th Annual Laser Surgery...
09/22/2008
The Dermatologist
Chief Medical Editor Message
09/22/2008
A March 21, 2008, New York Times article1 described some of the financial ties physicians have to drug companies. The details of some of these ties became public due to openness legislation in some states. The Minnesota Legislature passed a...
A March 21, 2008, New York Times article1 described some of the financial ties physicians have to drug companies. The details of some of these ties became public due to openness legislation in some states. The Minnesota Legislature passed a...
A March 21, 2008, New York Times...
09/22/2008
The Dermatologist
